Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
NCT02917798 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1047
Last updated 2025-10-07
Summary
This study will evaluate patients' experiences with having gynecologic or prostate medical oncologists and surgeons offer them genetic testing, and having genetic counselors return the test results to patients over the telephone. This is different from the usual approach to genetic testing, where gynecologic or prostate medical oncologists and surgeons refer their patients to a genetic counselor in order to have these tests done, and the genetic counselors return the test results to the patient in person or over the telephone. The investigators will only be evaluating this alternative way of providing genetic testing to ovarian or prostate cancer patients.
Conditions
- Ovarian Cancer
- Prostate Cancer
- Pancreas Cancer
Interventions
- BEHAVIORAL
-
Assessments
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Maria Carlo, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-12
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- United States
Study Locations
More Related Trials
-
Genetic Testing Decision Aid
NCT05470920 ·Status: RECRUITING ·Phase: NA
-
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
NCT05420064 ·Status: RECRUITING ·Phase: NA
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
NCT05266300 ·Status: COMPLETED
-
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
NCT02706652 ·Status: TERMINATED
-
Genetic Testing for Men With Metastatic Prostate Cancer
NCT03503097 ·Status: TERMINATED
-
Choices About Genetic Testing And Learning Your Risk With Smart Technology
NCT06184867 ·Status: COMPLETED ·Phase: NA
-
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
NCT05664867 ·Status: RECRUITING ·Phase: NA
-
Increasing Germline Genetic Testing for Patients With Cancer
NCT07307664 ·Status: RECRUITING ·Phase: NA
-
Prospective Registry of Multiplex Testing (PROMPT)
NCT02665195 ·Status: ACTIVE_NOT_RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
NCT02610413 ·Status: RECRUITING
-
The Genetic Education for Men Trial: Web-Based Education vs. Standard Care
NCT02957981 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
NCT04067960 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Genomic Profiling in Cancer Patients
NCT01775072 ·Status: RECRUITING
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Genetic Testing in Young Adults With Cancer Study
NCT04533555 ·Status: COMPLETED ·Phase: NA
-
Strategic Targeting for Optimal Prevention of Cancer
NCT03897374 ·Status: RECRUITING
-
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer
NCT05958082 ·Status: RECRUITING ·Phase: NA
-
Cancer DNA Detection in Blood and Urine
NCT02657863 ·Status: COMPLETED
-
Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes
NCT06914726 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA
-
Michigan Genetic Hereditary Testing (MiGHT)
NCT05162846 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention
NCT06436157 ·Status: RECRUITING ·Phase: NA
-
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis
NCT02213822 ·Status: UNKNOWN
-
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT03617939 ·Status: RECRUITING